Sleepisol Lite, utilizing Leesol's patented technology, overcomes the effectiveness issue of traditional tACS due to skin barrier interference, improving Beck-Depression Inventory-II(BDI-II) scores by 175%. This remarkable improvement was demonstrated in a randomized controlled trial with 60 insomnia patients at Seoul National University Bundang Hospital.

The device is a lightweight, wearable headband that makes mental health management easy with just a single button. Weighing only 33g and featuring a built-in AAAA battery, it eliminates the need for frequent charging, making it highly portable and convenient. Users can maintain consistent care anywhere, ensuring long-term benefits and improved well-being.